The bias of the sample proportion following a group sequential phase II clinical trial

Myron N. Chang; Harry S. Wieand; Vivian T. Chang

doi:10.1002/sim.4780080505

The bias of the sample proportion following a group sequential phase II clinical trial

Statistics in Medicine ◽

10.1002/sim.4780080505 ◽

1989 ◽

Vol 8 (5) ◽

pp. 563-570 ◽

Cited By ~ 18

Author(s):

Myron N. Chang ◽

Harry S. Wieand ◽

Vivian T. Chang

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Group Sequential ◽

Sample Proportion ◽

Sequential Phase

Download Full-text

Improved confidence intervals for a binomial parameter following a group sequential phase II clinical trial

Statistics in Medicine ◽

10.1002/sim.1878 ◽

2004 ◽

Vol 23 (18) ◽

pp. 2817-2826 ◽

Cited By ~ 4

Author(s):

Myron N. Chang

Keyword(s):

Clinical Trial ◽

Confidence Intervals ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Group Sequential ◽

Binomial Parameter ◽

Sequential Phase

Download Full-text

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial

Vaccine ◽

10.1016/j.vaccine.2008.11.003 ◽

2009 ◽

Vol 27 (5) ◽

pp. 786-791 ◽

Cited By ~ 35

Author(s):

N. Groth ◽

E. Montomoli ◽

C. Gentile ◽

I. Manini ◽

R. Bugarini ◽

...

Keyword(s):

Clinical Trial ◽

Cell Culture ◽

Influenza Vaccine ◽

Phase I ◽

Mammalian Cell ◽

Phase Ii ◽

Mammalian Cell Culture ◽

Phase Ii Clinical Trial ◽

Sequential Phase

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

A result of phase II clinical trial for the dermatomycosis of new antifungus external preparation KP-363 ( butenafine hydrochloride ) cream and liquid.

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.52.586 ◽

1990 ◽

Vol 52 (3) ◽

pp. 586-595 ◽

Cited By ~ 9

Author(s):

AKIRA OKAWARA

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

ORAL INTAKE OF PURIFIED AQUEOUS SOLUTION OF OAT ?-GLUCANS HAS NO EFFECT ON GASTRIC MUCOSA HISTOLOGICAL CHANGES IN PATIENTS WITH CHRONIC GASTRITIS: A PILOT PHASE II CLINICAL TRIAL

10.26226/morressier.57c5383cd462b80296c9c8fb ◽

2016 ◽

Author(s):

Rafal Filip

Keyword(s):

Clinical Trial ◽

Aqueous Solution ◽

Gastric Mucosa ◽

Phase Ii ◽

Chronic Gastritis ◽

Oral Intake ◽

Phase Ii Clinical Trial ◽

Pilot Phase ◽

Histological Changes

Download Full-text

Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran of Phase II Clinical Trial

Case Medical Research ◽

10.31525/ct1-nct04197323 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Lower Extremity ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

Faculty Opinions recommendation of A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727678658.793546414 ◽

2018 ◽

Author(s):

Jay H Ryu

Keyword(s):

Clinical Trial ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

SSRN Electronic Journal ◽

10.2139/ssrn.3212963 ◽

2018 ◽

Author(s):

Giuseppe Lombardi ◽

Gian Luca De Salvo ◽

Alba Ariela Brandes ◽

Marica Eoli ◽

Roberta Rudà ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text

The Effects of Rasagiline on Glucose Metabolism and Cognition and Their Relationship to Tau Burden in a Double-Blind, Placebo-Controlled Phase Ii Clinical Trial of Participants with Alzheimer's Dementia

SSRN Electronic Journal ◽

10.2139/ssrn.3544838 ◽

2020 ◽

Author(s):

Dawn Matthews ◽

Aaron Ritter ◽

Ronald G. Thomas ◽

Randolph D. Andrews ◽

Ana S. Lukic ◽

...

Keyword(s):

Clinical Trial ◽

Glucose Metabolism ◽

Phase Ii ◽

Alzheimer’S Dementia ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Alzheimer's Dementia ◽

Double Blind Placebo

Download Full-text

P2-027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2-NGF GENE THERAPY FOR ALZHEIMER'S DISEASE

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.06.711 ◽

2006 ◽

Vol 14 (7S_Part_12) ◽

pp. P677-P677

Author(s):

Michael J. Castle ◽

Fernando Calvo Baltanas ◽

Imre Kovacs ◽

Alan H. Nagahara ◽

Krystof S. Bankiewicz ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Gene Therapy ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Target Engagement ◽

Ngf Gene

Download Full-text